Patent Assignment
Reel/Frame 012277/0967
Assignment of Assignor's Interest
Recorded: 2001-10-19
Pages: 4
Assignor
GILLIES, STEPHEN D.
Executed: 2001-10-04
Assignee
LEXIGEN PHARMACEUTICALS CORPORATION
125 HARTWELL AVENUE, LEXINGTON, MASSACHUSETTS, 02173
Covered Property
(1)
Expression technology for fusion proteins containing an antibody moiety having reduced Fc effector functions
Application:
60/274,096 →
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.